chr16-69748962-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014062.3(NOB1):c.682G>A(p.Glu228Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014062.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOB1 | NM_014062.3 | c.682G>A | p.Glu228Lys | missense_variant | 6/9 | ENST00000268802.10 | |
NOB1 | NR_074074.2 | n.567G>A | non_coding_transcript_exon_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOB1 | ENST00000268802.10 | c.682G>A | p.Glu228Lys | missense_variant | 6/9 | 1 | NM_014062.3 | P1 | |
NOB1 | ENST00000561677.6 | n.368G>A | non_coding_transcript_exon_variant | 4/4 | 2 | ||||
NOB1 | ENST00000564620.5 | c.*350G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/7 | 2 | ||||
NOB1 | ENST00000569871.5 | c.*350G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000600 AC: 15AN: 250056Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135182
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461188Hom.: 0 Cov.: 34 AF XY: 0.00000688 AC XY: 5AN XY: 726812
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74386
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at